Johnson & Johnson buying Crucell for $2.41 billion

October 6, 2010 7:48:21 AM PDT
Johnson & Johnson said Wednesday it is buying Crucell N.V. for about $2.41 billion in a move that will boost the American health care company's vaccine business.

Load Comments